Nasdaq News

Key PointsBeginner investors often use the share price figure to determine a stock's size or relative "cheapness," but this is a major mistake.

(RTTNews) - FibroBiologics, Inc. (FBLG), a clinical-stage biotechnology company, announced that the European Patent Office has granted European Patent No. 3568465, titled "Methods of Enhancing Fibroblast Therapeutic Activity," covering its fibroblast therapeutic technology.

(RTTNews) - Atossa Therapeutics (ATOS) announced that its Board has approved a plan to issue one contingent value right (CVR) for each share of common stock, linking shareholders to potential proceeds from the company's first qualifying Rare Pediatric Disease Priority Review Vouc

Key PointsWarren Buffett retired as Berkshire’s CEO on Dec. 31, handing the keys to the company’s $358 billion investment portfolio to Greg Abel.

Key PointsThe AI boom has been lucrative for the market, but it's tough to say how long it might last.

Key PointsSpaceX's revenue is increasing at a breakneck clip. Starlink and AI will help sustain the momentum.

(RTTNews) - Liminatus Pharma, Inc. (LIMN), a biotechnology company developing immuno-oncology and cell therapy candidates, announced that it has regained compliance with Nasdaq's minimum bid price rule.

Key PointsBoeing recently landed a $131 billion contract to enhance the Air Force’s F-15 fighter jet.

Key PointsPalantir has emerged as the gold standard in enterprise artificial intelligence due to its unique software architecture.

Key PointsMarket valuation metrics and margin debt levels are at historically high levels.

October NY world sugar #11 (SBV26 ) is up +0.46 (+2.63%) today, and December London ICE white sugar #5 (SWZ26 ) is up +7.40 (+1.47%). Sugar prices are moving higher today, with London sugar posting a 1-week high. Prices are trading sideways within a wide month-long range, between last Tuesday’s...

(RTTNews) - Mayne Pharma Group Ltd. (MYX.AX) announced that Sun Pharmaceutical Industries Ltd. (SUNPHARMA.NS) has agreed to settle U.S. Paragraph IV patent litigation concerning IMVEXXY and its associated FDA Orange Book-listed patents.

(RTTNews) - On Tuesday, Argenx SE (ARGX) announced that it will present new clinical, long-term and real-world data for VYVGART (efgartigimod) across Myasthenia gravis and Chronic inflammatory demyelinating polyneuropathy (CIDP), along with updates from its neuromuscular pipeline

Key PointsWalmart and WM operate businesses that consumers consistently need.

Key PointsNadella turned around Microsoft by focusing on enterprise cloud solutions in both software and compute.

Key PointsThe S&P 500 is on pace for its fourth consecutive year of double-digit gains amid strong financial results driven by heavy spending on AI.

Key PointsIt’s been a year of historic change at the nation’s central bank, with new Fed Chair Kevin Warsh kicking off only the fourth rate-hiking cycle of the 21st century on Sept. 16.

(RTTNews) - Zealand Pharma A/S (ZEAL.CO), a biotechnology company, on Wednesday announced the publication of new results from the Phase 3 ZUPREME-1 trial for Petrelintide in weight management. The data was published in The Lancet Diabetes and Endocrinology journal.

Fintel reports that on September 29, 2026, Scotiabank initiated coverage of Xcel Energy Inc. - Preferred Stock (NASDAQGM:XELLL) with a Sector Outperform recommendation. On the day of the coverage initiation, September 29, 2026, the stock's latest close was $20.96. This followed a

Key PointsBroadcom's fourth-quarter gains since 2013 ran from under 3% to around 37%.